Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

Widmark A, Klepp O, Solberg A, Damber JE, Angelsen A, Fransson P, Lund JA, Tasdemir I, Hoyer M, Wiklund F, Fosså SD; Scandinavian Prostate Cancer Group Study 7.; Swedish Association for Urological Oncology 3..

Lancet. 2009 Jan 24;373(9660):301-8. doi: 10.1016/S0140-6736(08)61815-2. Erratum in: Lancet. 2009 Apr 4;373(9670):1174.

2.

Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.

Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019. Review.

PMID:
17054269
3.

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Nair B, Wilt T, MacDonald R, Rutks I.

Cochrane Database Syst Rev. 2002;(1):CD003506. Review.

PMID:
11869665
4.

Locally advanced prostate cancer: effective treatments, but many adverse effects.

[No authors listed]

Prescrire Int. 2013 Jan;22(134):18-20, 22-3. Review.

PMID:
23367679
5.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
6.

Endocrine treatment of prostate cancer.

Tammela T.

J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Review.

PMID:
15663992
8.

[Endocrine therapy for localized or locally advanced prostate cancer].

Fontaine E, Ruffion A, Staerman F.

Prog Urol. 2004 Jun;14(3):433-6. Review. French.

PMID:
15373195
9.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Wilt TJ, MacDonald R, Rutks I, Shamliyan TA, Taylor BC, Kane RL.

Ann Intern Med. 2008 Mar 18;148(6):435-48. Review. Erratum in: Ann Intern Med. 2008 Jun 3;148(11):888.

PMID:
18252677
10.

Synergistic action of image-guided radiotherapy and androgen deprivation therapy.

Locke JA, Dal Pra A, Supiot S, Warde P, Bristow RG.

Nat Rev Urol. 2015 Apr;12(4):193-204. doi: 10.1038/nrurol.2015.50. Review.

PMID:
25800395
11.

Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer.

Thoms J, Goda JS, Zlotta AR, Fleshner NE, van der Kwast TH, Supiot S, Warde P, Bristow RG.

Nat Rev Clin Oncol. 2011 Feb;8(2):107-13. doi: 10.1038/nrclinonc.2010.207. Review.

PMID:
21178999
12.

Is there a best endocrine treatment of prostate cancer?

Schröder FH.

J Clin Endocrinol Metab. 1995 Apr;80(4):1071-4. Review. No abstract available.

PMID:
7714069
13.

Hormone therapy in combination with radiotherapy in the treatment of prostate cancer: why and in which group of patients?

Milecki T, Antczak A, Kwias Z, Milecki P.

Contemp Oncol (Pozn). 2015;19(1):1-5. doi: 10.5114/wo.2015.50010. Review.

Items per page

Supplemental Content

Support Center